Olga Ovcinnikova - Publications, H-index & Citations

Olga Ovcinnikova

takeda development center americas, inc.

5H指数

23论文数

137被引数

收录论文 11

发表时间

The clinical and economic burden of peripheral T-cell lymphoma: a systematic literature review

FUTURE ONCOLOGY

IF2.6

2021-12-01

OAAI

Ashaye, Ajibade O.; Burnett, Heather; Abogunrin, Seye; Panchmatia, Hemangi; Ovcinnikova, Olga; Dalal, Mehul

Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America 医疗保健决策中的真实世界证据: 全球趋势和拉丁美洲的案例研究

VALUE IN HEALTH

IF6

2019-06-01

OAAI

Justo, Nahila; Espinoza, Manuel A.; Ratto, Barbara; Nicholson, Martha; Rosselli, Diego; Ovcinnikova, Olga; Marti, Sebastian Garcia; Ferraz, Marcos B.; Langsam, Martin; Drummond, Michael F.

HEALTHCARE RESOURCE USE IN PATIENTS WITH END-STAGE ADVANCED CUTANEOUS T-CELL LYMPHOMA (CTCL): RESULTS OF SEVEN SEMI-STRUCTURED INTERVIEWS ACROSS LEADING UK CENTRES

VALUE IN HEALTH

IF6

2018-10-01

OAAI

Podkonjak, T.; Ovcinnikova, O.; Cranmer, H.; Benson, E. M.; Hatswell, A. J.; Field, F.

The Burden of Uncontrolled Glycemia-A Systematic Literature Review

DIABETES

IF7.5

2018-07-01

PREAI

Fernandes, Gail; Iff, Joel; Ovcinnikova, Olga; Nassim, Maria; Sun, Lucy; Richards, Margaret S.; Rajpathak, Swapnil

COMPARISON OF EARLY SCIENTIFIC ADVICE PROCESSES IN UK, FRANCE AND GERMANY (HTA ONLY): TIPS AND TRICKS

VALUE IN HEALTH

IF6

2017-10-01

OAAI

Vlachaki, I; Ovcinnikova, O.; Storck, C.; El Mouaddin, N.; Shah, M.

COST OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB AS FIRST LINE TREATMENT IN ADVANCED MELANOMA ACROSS VARIOUS EUROPEAN MARKETS

VALUE IN HEALTH

IF6

2017-10-01

OAAI

Ovcinnikova, O.; Bourhis, F.; Shah, M.; Potluri, R.; Chirita, O.; Sabater, J.; Di Rienzo, P.

ANALYSIS OF RECENT APPROVALS OF IMMUNO-ONCOLOGY DRUGS ACROSS ENGLAND, SCOTLAND, GERMANY AND FRANCE

VALUE IN HEALTH

IF6

2017-10-01

OAAI

Ziomek, J.; El Mouaddin, N.; Ng, T.; Ovcinnikova, O.; Taveau, C.

COST-EFFECTIVENES OF CETUXIMAB IN FIRST-LINE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER IN BELGIUM AND THE NETHERLANDS

VALUE IN HEALTH

IF6

2015-11-01

OAAI

Krol, M.; Ovcinnikova, O.; von Hohnhorst, P.; Jarrett, J.

ARE VACCINES GETTING A FAIR DEAL? HEALTH TECHNOLOGY ASSESSMENT OF VACCINES ACROSS EUROPE

VALUE IN HEALTH

IF6

2015-11-01

OAAI

Wei, C.; Jarrett, J.; Ovcinnikova, O.; Bending, M. W.

COST EFFECTIVENESS OF CETUXIMAB IN 1ST-LINE TREATMENT OF RAS WILD-TYPE METASTATIC COLORECTAL CANCER IN SCOTLAND: A SUMMARY OF THE SUBMISSION TO THE SCOTTISH MEDICINES CONSORTIUM

VALUE IN HEALTH

IF6

2014-11-01

OAAI

Jarrett, J.; Ovcinnikova, O.; Hnoosh, A.; Harty, G.; Byrne, B.; von Hohnhorst, P.

AN ANALYSIS OF THE HEALTH TECHNOLOGY ASSESSMENT RECOMMENDATION AND GUIDANCE ON USE OF EQ-5D-5L IN COST-EFFECTIVENESS MODELING

VALUE IN HEALTH

IF6

2014-11-01

OAAI

Ovcinnikova, O.; Firth, Z. A.; Dimova, M.

研究方向